Supramolecular nanosubstrate–mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathies

Leveraging the endogenous homology-directed repair (HDR) pathway, the CRISPR-Cas9 gene-editing system can be applied to knock in a therapeutic gene at a designated site in the genome, offering a general therapeutic solution for treating genetic diseases such as hemoglobinopathies. Here, a combined s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Peng, Chou, Shih-Jie, Li, Jindian, Hui, Wenqiao, Liu, Wenfei, Sun, Na, Zhang, Ryan Y., Zhu, Yazhen, Tsai, Ming-Long, Lai, Henkie I., Smalley, Matthew, Zhang, Xinyue, Chen, Jiayuan, Romero, Zulema, Liu, Dahai, Ke, Zunfu, Zou, Chang, Lee, Chin-Fa, Jonas, Steven J., Ban, Qian, Weiss, Paul S., Kohn, Donald B., Chen, Kai, Chiou, Shih-Hwa, Tseng, Hsian-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608838/
https://www.ncbi.nlm.nih.gov/pubmed/33097539
http://dx.doi.org/10.1126/sciadv.abb7107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608838/
https://www.ncbi.nlm.nih.gov/pubmed/33097539
http://dx.doi.org/10.1126/sciadv.abb7107

Ejemplares similares